Health · 45 views
Prostate cancer prognosis linked to prostate-specific antigen levels below threshold
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working.
Summary
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published online in CANCER.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Clinician AI Use; Predicting Bad Infant Outcomes in Labor; Donor Heart DistributionContinue reading
- 10 years after Ebola in West Africa: Laboratory partnership improves viral hemorrhagic fever diagnostics in GuineaContinue reading
- An Accurate Census Protects Our HealthContinue reading
- Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trialsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow